MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

SciClone Pharmaceuticals Company Profile (NASDAQ:SCLN)

Consensus Ratings for SciClone Pharmaceuticals (NASDAQ:SCLN) (?)
Ratings Breakdown: 1 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $9.00 (18.63% downside)

Analysts' Ratings History for SciClone Pharmaceuticals (NASDAQ:SCLN)
Show:
DateFirmActionRatingPrice TargetActions
6/29/2015MLV & Co.Initiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2015AegisReiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/19/2014AegisSet Price TargetBuy$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/14/2014BWS FinancialDowngradeBuy -> Hold$8.25 -> $8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/29/2014AegisReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/12/2013AegisLower Price TargetBuy$9.00 -> $8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/25/2013AegisReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/16/2013AegisUpgradeHold -> Buy$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/4/2013 forward)